The National Cancer Center will promote a multidisciplinary model of cancer diagnosis and treatment

Cai Jianqiang, deputy director of the National Cancer Center and vice president of the Oncology Hospital of the Chinese Academy of Medical Sciences, said at the 3rd China Cancer Summit Forum that under the multidisciplinary diagnosis and treatment model (MDT), the development of accurate personalized treatment plan can maximize the lives of patients with advanced cancer, and even give them a chance of cure.
National Cancer Center will comprehensively promote the MDT model to help achieve the goal of cancer prevention and treatment in China.
MDT refers to patient-centered, multidisciplinary experts involved in the disease to discuss, to clear the diagnosis of patients in stages, the development of appropriate treatment plan model.
national health board has launched a nationwide pilot on oncology MDT between 2018 and 2020.
Cai Jianqiang said that the current general mode of diagnosis and treatment of cancer patients in China is, who is the first to "catch" patients who see, often "headache, foot pain."
patients may be subjected to repeated tests, overtreated treatment, inappropriate treatment, etc. in such a treatment mode, resulting in missed opportunities for optimal treatment.
does MDT mean for patients with advanced cancer? Take China's high incidence of colorectal cancer as an example, because of the hidden disease, early no obvious symptoms and easy to miss diagnosis, easy transfer and recurrence, many patients found that it is late.
Chinese Academy of Medical Sciences Cancer Hospital in 2007 took the lead in establishing a colorectal cancer liver metastasis MDT collaboration group, and has gradually established a consensus of diagnosis and treatment experts and special disease associations.
data show that the five-year survival rate of patients treated by the MDT collaborative group has reached 46%, which has reached the international advanced level.
china's cancer prevention and control action proposed that by 2030, the overall cancer five-year survival rate is not less than 46.6%. More than
participating academicians and experts in the field of oncology said that the current conditions in China to significantly reduce morbidity and mortality is the digestive system tumors, such as esophageal cancer, stomach cancer, bowel cancer.
and MDT, the five-year survival rate of these tumors has been significantly improved, which is of great significance to the realization of cancer prevention and treatment goals.